The Latin America Task Force has launched a new webinar series, Pulmonary Hypertension in Latin America, which began on 28 October 2025.
This four-part series — three of which are in Spanish, a first for PVRI — is designed for a LATAM audience and explores regional perspectives on pulmonary hypertension (PH), from diagnosis and classification to treatment approaches.
Upcoming session Group 2 Pulmonary Hypertension — associated with heart failure and fluid retention 16 December 2025, 15:00 GMT Delivered in Spanish with subtitles available
This second session will review diagnosis, classification (7th WSPH), and treatment strategies, including CpcPH management, with a live case discussion and insights from international experts. Register for free
Previous session PH evaluation and regional differences The opening webinar examined diagnostic evaluation, differential diagnosis, and how PH phenotypes differ between Latin America and the USA/Europe. Watch now
The LATAM group held their 5th Paediatric & 2nd Adult LATAM PH Symposium, in Sao Paulo, Brazil, in November 2024. The meeting addressed the latest advances in diagnosis and management of adult and paediatric PH and explored avenues to increase partnerships between adult and paediatric physicians to improve clinical outcomes and quality of life for PH patients across their entire lifespans.
PVRI is delighted to have provided a travel award for this meeting for an early career PH colleague from a low-income country, plus support for faculty travel.
If you are interested in joining this Task Force, please get in touch.
Leaders
Vinicio de Jesus Perez, Stanford University
Gabriel Diaz, Universidad Nacional de Colombia
Gustavo Heresi, Cleveland Clinic
Mauricio Orozco-Levi, Universidad Nacional de Colombia
Tomas Pulido, Instituto Nacional de Cardiología
Rogerio Souza, University of Sao Paulo Medical School
Our Regional Task Forces don't yet have global coverage. If you're interested in starting one, please contact us.
Interested in accessing global data on PH patient experience? Almost 4,000 patients and carers across 85 countries completed Phase 1 of our PH Global Patient Survey (PHGPS). Questions across all PH groups included diagnostic tests & timelines, genetic testing, treatments, financial burdens, hospital visits, research participation, quality of life, telemedicine, patient-reported outcome measures, and self-monitoring with digital technology. The findings have the potential to improve patient care, guide future research and help us address unmet needs.
